Navigation Links
Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease
Date:4/15/2008

s a stabilizer accounted for a disproportionate share of the total number.

Glycine, an amino acid, is used as a stabilizer. GAMMAGARD LIQUID does not contain sucrose.

GAMMAGARD LIQUID is made from human plasma. It may carry a risk of transmitting infectious agents, viruses, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

Components used in the packaging of this product are latex-free.

Thrombotic events have been reported in association with IGIV. Patients at risk may include those with a history of atherosclerosis, multiple cardiovascular risk factors, advanced age, impaired cardiac output, and/or known or suspected hyperviscosity, hypercoagulable disorders, and prolonged periods of immobilization.

IGIV products can contain blood group antibodies that may cause a positive direct antiglobulin reaction and, rarely, hemolysis.

Aseptic meningitis syndrome (AMS) has been reported to occur infrequently in association with IGIV treatment. Discontinuation of IGIV treatment has resulted in remission of AMS within several days without sequelae.

Various mild and moderate reactions, such as headache, fever, fatigue, chills, flushing, dizziness, urticaria, wheezing or chest tightness, nausea, vomiting, rigors, back pain, chest pain, muscle cramps, and changes in blood pressure may occur with infusions of Immune Globulin Intravenous (Human).

For full prescribing information, please visit http://www.gammagardliquid.com.

About Alzheimer's Disease

Alzheimer's disease is the most common form of dementia, a clinical condition, which involves the decline or loss of memory and other cognitive abilities. A progressive and ultimately fatal disease marked by severe brain tissue deterioration, Alzheimer's disease initially involves the parts of the brain that control thought, memory and language. The number of new Alzheimer's disease cases diagnosed
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Kline Study: Better Brushing Habits Boost European Oral Care Sales
4. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
5. NASA study will help stop stowaways to Mars
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
9. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
10. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
11. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...ompany Provides Fourth Quarter 2008 and Full Year ..., Del., Dec. 4 DuPont, ...ddress current market challenges and strengthen th...tinued focus on maximizing cash flow, and provided... the full year 2009. , , A steep global dec...
(Date:12/4/2008)..., , TUSTIN, Calif., Dec. 4 /PRNewswire-Fir...q: PPHM ) today announced that it will release i...cal year 2009 on December 10, 2008 at 7:00 a.m. ES...iscuss the results at 11:30 a.m. EST on the same d... discuss financial results for the second quarter ...
(Date:12/4/2008)...EW YORK, Dec. 4 Delcath ...at Jonathan Lewis, M.D., Ph.D., has stepped down f...ective December 2, 2008. Dr. Lewis advised the Co... is a result of additional commitments to new lead...ewscom.com/cgi-bin/prnh/20081118/NY46990LOGO ) , ...
(Date:12/4/2008)...UEBEC CITY, Dec. 4 /PRNewswire-FirstCall/ - AEtern...bal biopharmaceutical company focused on endocrine...esident and CEO, Juergen Engel, Ph.D., will take p...ainstay With Newer And Better Agents" at the upcom... on Wednesday, December 10, 2008 at 4:30 pm (easte...
Breaking Biology Technology:DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 2DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 3DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 4DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 5DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 6Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2
... annual review of 2005, here,s a quick recap of so...eek we,ll expand our scope and republish some of o... analysis this year. , , Stem cells , ,They could...n though very few companies or organizations here ...tem cells, the scientists at the Madison campus co...
...on of three Medical College of Wisconsin radiology...s, brains. Kyron Clinical Imaging Inc. received FD...developing, the Milwaukee Journal-Sentinel report...from a magnetic resonance imaging, or MRI, scanner...at it could present several different views of the...
... reported revenue up 86 percent and a narrowed net...media presentation hardware and software for busin... was $8.3 million, compared to last year,s $4.4 mi...ss, a slight improvement over last year,s $5.4 mil...m,s growth phase, which also involved increasing s...
... cost and financing of health care in the United S... , , About one in seven Americans (15.7 percent) ...ion people. , , According to the latest federal fi...f the nations economy. Health care spending of $1....merican. By 2013, the government forecasts, health...
Other Biology Technology:Stem-cell debate, wireless access and other endeavors heat up 2Stem-cell debate, wireless access and other endeavors heat up 3Stem-cell debate, wireless access and other endeavors heat up 4Health care economics make definition of 'cost' problems difficult 2Health care economics make definition of 'cost' problems difficult 3
(Date:12/3/2008)..., , Scientists from Scripps Institution of Oceano...editions in Mexico have captured unprecedented det...f of California, including documentations of new s...ive. Yet the expeditions, which included surveys a...ines in sea-life populations and evidence that hum...
(Date:12/3/2008)..., Using a harmless virus to insert a corrective g... Children,s Research Hospital have alleviated sick...esearchers found that the treated mice showed esse...he scientists caution that applying the gene thera...les, they believe that the new therapy will become...
(Date:12/3/2008)..., A recent ESA campaign has demonstrated how a te...carbon dioxide in the atmosphere. The campaign sup...Earth Explorer A-SCOPE mission. , A-SCOPE (Advan... Earth) is one of the six candidate Earth Explorer.... The mission concept, along with the other five, ...
(Date:12/3/2008)..., Deerfield, IL, December 3, 2008 Today, the Int... the world,s leading professional organization of ... the responsible development of safe and effective...ticle that summarizes the Guidelines for the Clini... Cell Press in the December issue of Cell Stem Ce...
Breaking Biology News(10 mins):Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 2Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 4Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3ESA tests laser to measure atmospheric carbon dioxide 2ESA tests laser to measure atmospheric carbon dioxide 3The International Society for Stem Cell Research releases new guidelines 2The International Society for Stem Cell Research releases new guidelines 3Morse CyberKnife CEO James G Schwade M D Announces Non Surgical Treatment With CyberKnife Radiosurgery for Prostate Cancer 2942 1Characterization of grapevine transposons furthers understanding of in vino variety 4681 1Scientists grow nanonets able to snare added energy transfer 7436 1Scientists grow nanonets able to snare added energy transfer 7436 2Energy saving bacteria resist antibiotics 4680 1Energy saving bacteria resist antibiotics 4680 2
...With the introduction of just four factors, resear...ls taken from mouse embryos or adult mice to behav...ted their findings in an immediate early publicati..., The cells--which the researchers designate "indu...sical, growth, and genetic characteristics typical...
...An enzyme that helps neurons rid themselves of exc...ain function, according to a new report in the Aug...by Cell Press. What,s more, by increasing brain le...ms, the researchers found they could reverse lapse...ease. , Treatments that elevate the protein, know...
...Bacteria and fungi, some with the potential to cau...eir way from Africa to the Americas by hitchhiking... in the Sahara, according to research presented to...ociety for Microbiology in Orlando, Florida. , "T...al and transport of microorganisms from North Afri...
...Researchers have identified the genes in gum-disea...uman arterial cells, offering one possible explana...e and heart disease. Scientists from the Universi... today at the 106th General Meeting of the America... "Aside from lifestyle and genetic factors, there ...
Other Biology News:With few factors, adult cells take on character of embryonic stem cells 2Brain enzyme treatment relieves memory lapse in Alzheimer's mice 2Brain enzyme treatment relieves memory lapse in Alzheimer's mice 3Microbes hitchhike across Atlantic on desert dust 2
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin
...nce FLA-7000 excels at fluorescent and radioisotop...gel documentation. It features four easy-to-access... filter for Imaging Plates) for upgrading flexibil...le choice of four kinds of excitation laser beams....
The Microarray Gene Frame® has been specifically designed for microarray slide hybridisations. These frames feature the same dual strength adhesive system as our standard Gene Frame® range
... and Labeling Kit generates labeled cDNA for use i...dified cDNA is made via a reverse transcription fr...e other methods, there are no unnatural modified n...ion. This unmodified cDNA is then labeled in a one...
Biology Products: